Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial proton gradient is an electrochemical gradient across the inner mitochondrial membrane, essential for ATP synthesis. It is generated by the electron transport chain pumping protons from the mitochondrial matrix to the intermembrane space, creating a protonmotive force. This force drives ATP synthesis as protons flow back into the matrix through ATP synthase. The gradient's regulation and dissipation are critical for energy conversion efficiency and are implicated in various diseases.
The proton gradient itself is not directly targeted by drugs. Instead, drugs interact with components that generate or dissipate the gradient, such as the electron transport chain, ATP synthase, or uncoupling proteins. The overall effect on the proton gradient depends on the specific drug and its mechanism.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Proton Gradient.